The company distributes its products directly, as well as through distributors and license-holders primarily to hospitals, clinics, radiology centers, purchasing pools, and wholesalers. Further, the company offers delivery systems and services comprising injectors consumables for various types of injectors Contrast&Care, a patient data management software Dose&Care, an operational solution for monitoring patient exposure to ionizing radiation and Hydra Vision, a digital imaging system for urological, gastroenterological, gynecological treatment, and planning and diagnostic procedures. In addition, it provides products for interventional imaging, including Lipiodol ethyl esters of iodinated fatty acids of poppy seed oil Vectorio, a classic transarterial chemoembolization mixing and injection system Patent Blue V, an injectable medium and SeQure and DraKon, a microcatheters.
The company's products for the magnetic resonance imaging examinations comprise Dotarem, a non-specific gadolinium-based contrast medium Artirem products and Optimark, a contrast medium.
Its products for the CT and Cath Lab examinations include Optiray, a low osmolar contrast medium Xenetix, a low-osmolar iodinated agent Telebrix, a high osmolar contrast medium Conray and MD high osmolar contrast medium products Hexabrix, an ionic low osmolar contrast medium agent and Micropaque/ Microtrast, a diagnostic imaging interconnected solution. Guerbet SA engages in the research, development, production, and sale of contrast media products, delivery systems, medical devices, and related solutions worldwide.
0 kommentar(er)
